Photodynamic therapy as a promising approach for urinary tract tumors: Current evidence and future challenges

View at publisher Summarise with VIRAT
Authors: T. V. Sakhno, D.М. Ivashchenko, Boris F. Minaev, Yuriy E. Sakhno, M.I. Kravtsiv
Cited by: 0
References: 88

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Photodynamic therapy (PDT) is an advanced treatment method extensively used in oncology and other medical fields due to its ability to selectively destroy pathological cells. PDT operates through the activation of photosensitizers (PS) by light of a specific wavelength, resulting in the formation of reactive oxygen species (ROS) that cause cellular damage. PDT can be classified into three main approaches: tumor-targeted PDT, vascular-targeted PDT, and antimicrobial PDT. In oncology, PDT is predominantly used to target cancer cells while minimizing damage to healthy tissues. Additionally, PDT has shown promise in the diagnosis and treatment of bladder tumors, expanding its role in urological oncology. The mechanism of PDT in prostate cancer highlights its ability to target tumor vasculature, inducing ischemic necrosis while preserving surrounding tissues. The evolution of photosensitizers, particularly in prostate cancer, has led to second-generation compounds that offer faster, more efficient treatments with fewer side effects.

Fields of Study & Subjects

Photodynamic Therapy Research Studies Bladder and Urothelial Cancer Treatments Nanoplatforms for cancer theranostics

Publication details

Journal / source
Main Group Chemistry
Publication date
25 March 2026
Language
EN